Hani Gabra

Professor of Medical Oncology, Imperial College, London; Chief Physician Scientist and Vice President Head of Oncology Discovery Unit, Early Clinical Development IMED Biotech Unit, AstraZeneca, UK

  • Garry Weston Centre, Hammersmith Hospital, 150 Du Cane Road, Shepherd's Bush London W12 0HS
  • www.imperial.ac.uk


Biography

Hani Gabra is Professor of Medical Oncology at Imperial College, London.

He is also Professor of Personalised Cancer Medicine at the Centre for Cancer Biomarkers at University of Bergen, Norway.

Hani is also Chief Physician Scientist and Vice President head of Oncology Discovery Unit, Early Clinical Development IMED Biotech Unit, AstraZeneca Cambridge, UK

Hani studied Medicine at the University of Glasgow and graduated with a BSc (Hons) in Molecular Biology and MB ChB in 1987. After obtaining MRCP(UK) in 1990, he undertook an MSc in Clinical Oncology and a PhD in Molecular Oncology from the University of Edinburgh. He then completed his specialist training in Cancer Medicine in Edinburgh and was CRUK Clinical Scientist and Consultant Medical Oncologist at the CRUK Edinburgh Medical Oncology Unit from 1998-2003 when he came to Imperial as Chair in Medical Oncology.

He is a Fellow of the Royal College of Physicians of Edinburgh and London.

As well as leading the Ovarian Cancer Programme at Imperial, his laboratory is involved in trying to understand the role of tumour suppressor genes in ovarian cancer, particularly how OPCML regulates networks of receptor tyrosine kinases and how WWOX acts to regulate taxane sensitivity.

His clinical / translational interests relate to the understanding of platinum resistance in ovarian cancer, and he has developed several molecular targets whose inhibition can reverse platinum resistance from laboratory to clinic; such targets include AKT, MTOR, HDAC4, STAT1 and the Folate Receptors.

He is President of the European Translational Ovarian Cancer Network (EUTROC), a multinational group that undertakes science in ovarian cancer clinical trials, principally in the context of complex phase II clinical trials.

Education & Experience


Education

Title:
Ph.D
Degree:
Oncology and Molecular Genetics
Institution:
The University of Edinburgh
Date:
1992 - 1996
Country:
United Kingdom
Title:
MB ChB
Degree:
Medicine
Institution:
The University of Glasgow
Date:
1984 - 1987
Country:
United Kingdom


Experience

Title:
Cancer Research UK Clinical Scientist
Organisation:
University of Edinburgh
Date:
1998 - 2003
Title:
Honorary Consultant Medical Oncologist
Organisation:
Imperial College Healthcare NHS Trust
Date:
since 2003
Title:
Consultant Medical Oncologist
Organisation:
Private Practice
Date:
since 2010
Title:
Professor of Medical Oncology
Organisation:
Imperial College London
Date:
since 2003
Title:
Director
Organisation:
Ovarian Cancer Action Research Centre
Date:
2006 - 2016
Title:
Chief Physician Scientist and Vice President head of Oncology Discovery Unit, Early Clinical Development IMED Biotech Unit
Organisation:
AstraZeneca Cambridge, UK
Date:
None


Location

  • Garry Weston Centre, Hammersmith Hospital, 150 Du Cane Road, Shepherd's Bush London W12 0HS